$3.77
-0.19-4.67%
Last update: Nov 2, 4:00 PM
Camp4 Therapeutics Corp (CAMP) Stock Price, Quote, News & History
CAMPNASDAQ
Top analysts changed ratings on top names, including Sunrun, enGene Therapeutics, Camp4 Therapeutics, PennyMac Financial, Dave & Buster's, Neumora...
You can purchase shares of Camp4 Therapeutics (NASDAQ:CAMP) through any online brokerage.
Other companies in Camp4 Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Camp4 Therapeutics has a consensus price target of $10.33.
The stock price for Camp4 Therapeutics (NASDAQ: CAMP) is $3.775 last updated November 2, 2026 at 4:00 PM EST.
There are no upcoming dividends for Camp4 Therapeutics.
Camp4 Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Camp4 Therapeutics.
Camp4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases....
